LIMBER Prosthetics & Orthotics Awarded $200,000+ in Funding at San Diego Angel Conference V with Relavo Winning at Least $150,000 and Athletiverse Receiving at Least a $75,000 Investment

Winning team and runners up representing sports influencer marketing, prosthetics, healthtech, medical devices and services industries.

SAN DIEGO–(BUSINESS WIRE)–#AISan Diego Angel Conference (SDAC), a University of San Diego (USD) Knauss School of Business program now in its fifth year that activates accredited angel investors and engages promising early-stage companies, today awarded three startups with angel funding for their potentially disruptive solutions.

LIMBER Prosthetics & Orthotics took the top prize with $200,000* in funding for its affordable, personalized prosthetics.

Runners up were awarded funding as follows:

Relavo – $150,000*

Athletiverse – $75,000*

The SDAC V people’s choice honor went to LIMBER Prosthetics & Orthotics.

*Actual amount raised by the finalists could increase as investors may elect to invest in the startups as individual investors.

Today’s conference, the culmination of seven months of activating accredited angel investors, providing educational events and mentoring for participating early-stage companies, was presented live to an audience at University of San Diego (USD) and live streamed by the San Diego Angel Conference to an audience from across the country.

LIMBER Prosthetics & Orthotics CEO Dr. Joshua Pelz says, “What an honor to present alongside the other finalists today and be selected to receive funding from the SDAC fund. This seed funding will enable us to move our product development forward. SDAC also provided us with invaluable mentoring and lessons on how to effectively communicate with angel investors, complete the due diligence process, and build a strong network of mentors, investors, and peers.”

SDAC V received 106 applications from early-stage companies for the 2022/2023 season. Accredited angel investors nationwide invested anywhere from $7,000 to $40,000 to form a collective SDAC V fund. The angel investors evaluated the 106 startups over three months to determine those most likely to succeed and make it to the final pitch for funding.

Finalists included:

Athletiverse

LIMBER Prosthetics & Orthotics

Morari

PumpSpotting

Relavo

Wave Therapeutics

SDAC partners with 30+ organizations in the startup ecosystem. These connections, combined with SDAC’s reputation for excellence, enables it to attract promising startups and manage a substantial investment fund. SDAC sponsors include USD, C3 Bank, Mintz, SDSU, Knobbe Martens, First Republic Bank, Coeptus Law, Aquillius, Clearpoint Agency, Seraf, and UCSD.

SDAC Founder Mysty Rusk says, “Securing an angel investment doesn’t require affluence, education, or wealth. It requires a smart solution to a real-world problem and an entrepreneur with tenacity and a tolerance for risk. SDAC’s main objectives are to activate accredited investors and fund innovative early-stage companies. USD’s Free Enterprise Institute, Brink SBDC, and SDAC collaborate seamlessly to provide the infrastructure to ‘Get to yes!’, and USD continues to lead in values-driven free enterprise, enabling an enduring network of entrepreneurs, partners, sponsors, and investors.”

*Actual amount invested depends on total dollars raised. Historically, investors have exceeded both the investment amount and number of companies funded.

Contacts

Hilary McCarthy

[email protected]
774-364-1440

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.